Drugs / CART22
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02650414 | Jan 2016 → Dec 2037 expected | B-cell acute lymphoblastic leukemia | University of Pennsylvania | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CART22 | “0.2-1 x 10\^7 CART22 cells/kg” NCT02650414 ↗ |
| Modality | Cell therapy | “autologous T cells expressing CD22 chimeric antigen receptors” NCT02650414 ↗ |